GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genesystem Co Ltd (XKRX:363250) » Definitions » Institutional Ownership

Genesystem Co (XKRX:363250) Institutional Ownership : 7.99% (As of May. 28, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Genesystem Co Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Genesystem Co's institutional ownership is 7.99%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Genesystem Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Genesystem Co's Float Percentage Of Total Shares Outstanding is 0.00%.


Genesystem Co Institutional Ownership Historical Data

The historical data trend for Genesystem Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genesystem Co Institutional Ownership Chart

Genesystem Co Historical Data

The historical data trend for Genesystem Co can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 4.00 4.44 7.89 7.01 6.99 7.99 7.99 7.99 7.99 7.99

Genesystem Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Genesystem Co (XKRX:363250) Business Description

Traded in Other Exchanges
N/A
Address
200-9, Techno 2-ro, Yuseong-gu, Daejeon, KOR, 34028
Genesystem Co Ltd is a biotech engineering company specializing in molecular testing solutions that target on-site testing needs. It develops and markets state-of-the-art PCR platforms as well as related reagents and biochip products designed to enhance the health of human societies and improve the quality of human life.

Genesystem Co (XKRX:363250) Headlines

No Headlines